Quick Takeaways
- Opaleye Management Inc. filed SCHEDULE 13G/A for Protara Therapeutics, Inc. Common Stock (TARA).
- Disclosed ownership: 4.7%.
- Date of event: 31 Mar 2025.
Opaleye Management Inc. - 31 Mar 2025 SCHEDULE 13G/A Report for Protara Therapeutics, Inc. Common Stock (TARA)
- Filing Manager
- Opaleye Management Inc.
- Reporting Manager
- Opaleye Management, Inc.
- Symbol
- TARA
- Shares outstanding
- 36,730,361 shares
- Disclosed Ownership
- 1,730,000 shares
- Ownership
- 4.7%
- Form type
- SCHEDULE 13G/A
- Filing time
- 28 Apr 2025, 16:05:08 UTC
- Date of event
- 31 Mar 2025
- Previous filing
- 14 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Opaleye Management Inc. disclosed 4.7% ownership in Protara Therapeutics, Inc. Common Stock (TARA) on 31 Mar 2025."
What Changed
- Previous schedule filing date: 14 Feb 2025.
- Current filing was accepted on 28 Apr 2025, 16:05.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Opaleye Management, Inc. | 4.7% | 1,730,000 | 0 | 1,730,000 | /s/ James Silverman | President |